Literature DB >> 7524276

Preventive effect of intracisternal heparin for proliferative angiopathy after experimental subarachnoid haemorrhage in rats.

I H Tekkök1, S Tekkök, O E Ozcan, T Erbengi, A Erbengi.   

Abstract

Proliferative angiopathy represents the morphological basis of delayed cerebral vasospasm. The initial vasoconstriction and endothelial damage of the vasospastic arteries leads to an exaggerated response of the smooth muscle cells within the media leading to subintimal thickening and myonecrosis. Heparin reduces the exposure of the media to platelet derived growth factor, a mitogen from aggregating platelets responsible for the migration and proliferation of the myofibroblasts. Since systemic heparin in the setting of a subarachnoid haemorrhage would be unacceptable, we have tested the effect of heparin on proliferative angiopathy by injecting autologous non-heparinized blood into two groups of rats (N = 12 each) and then inject the heparin into the spinal fluid of one group after one hour. We were able to show histologically that intracisternal heparin injection after the subarachnoid haemorrhage has reduced the vascular wall changes to a great degree. Heparinization of the cerebrospinal fluid carried out in conjunction with early operation for aneurysms may be a promising approach to prevent the morbid complications of SAH in the clinical setting.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7524276     DOI: 10.1007/bf01808557

Source DB:  PubMed          Journal:  Acta Neurochir (Wien)        ISSN: 0001-6268            Impact factor:   2.216


  36 in total

1.  THE PATHOGENESIS OF CEREBRAL INFARCTION FOLLOWING THE RUPTURE OF CEREBRAL BERRY ANEURYSMS.

Authors:  M R CROMPTON
Journal:  Brain       Date:  1964-09       Impact factor: 13.501

2.  Comparison of intimal platelet accumulation in cerebral arteries in two experimental models of subarachnoid hemorrhage.

Authors:  Y Honma; B R Clower; J L Haining; R R Smith
Journal:  Neurosurgery       Date:  1989-04       Impact factor: 4.654

3.  Systemic heparin in the early management of ruptured intracranial aneurysms: review of 104 consecutive cases and comparison with concurrent controls.

Authors:  J Kapp; W R Neill; J E Salter; T Y Barnes
Journal:  Neurosurgery       Date:  1987-04       Impact factor: 4.654

4.  Cerebral arterial spasm. 3. Partial purification and characterization of a spasmogenic substance in feline platelets.

Authors:  J Kapp; M S Mahaley; G L Odom
Journal:  J Neurosurg       Date:  1968-10       Impact factor: 5.115

5.  Heparin inhibition of smooth muscle cell proliferation: a cellular site of action.

Authors:  C F Reilly; L M Fritze; R D Rosenberg
Journal:  J Cell Physiol       Date:  1986-10       Impact factor: 6.384

6.  Electron microscopy of simian cerebral arteries after subarachnoid hemorrhage and after the injection of horseradish peroxidase.

Authors:  F Espinosa; B Weir; T Shnitka
Journal:  Neurosurgery       Date:  1986-12       Impact factor: 4.654

7.  Safety and efficacy of intrathecal thrombolytic therapy in a primate model of cerebral vasospasm.

Authors:  J M Findlay; B K Weir; P Gordon; M Grace; R Baughman
Journal:  Neurosurgery       Date:  1989-04       Impact factor: 4.654

8.  Alterations of mechanical properties in canine basilar arteries after subarachnoid hemorrhage.

Authors:  P Kim; T M Sundt; P M Vanhoutte
Journal:  J Neurosurg       Date:  1989-09       Impact factor: 5.115

9.  The angiopathy of subarachnoid hemorrhage: angiographic and morphologic correlates.

Authors:  R R Smith; B R Clower; D F Peeler; J Yoshioka
Journal:  Stroke       Date:  1983 Mar-Apr       Impact factor: 7.914

10.  Kinetics of cellular proliferation after arterial injury. IV. Heparin inhibits rat smooth muscle mitogenesis and migration.

Authors:  A W Clowes; M M Clowes
Journal:  Circ Res       Date:  1986-06       Impact factor: 17.367

View more
  5 in total

Review 1.  Inflammation in subarachnoid hemorrhage and delayed deterioration associated with vasospasm: a review.

Authors:  J Javier Provencio
Journal:  Acta Neurochir Suppl       Date:  2013

Review 2.  Unfractionated heparin: multitargeted therapy for delayed neurological deficits induced by subarachnoid hemorrhage.

Authors:  J Marc Simard; David Schreibman; E Francois Aldrich; Bernadette Stallmeyer; Brian Le; Robert F James; Narlin Beaty
Journal:  Neurocrit Care       Date:  2010-12       Impact factor: 3.210

3.  Subarachnoid hemorrhage and the distribution of drugs delivered into the cerebrospinal fluid. Laboratory investigation.

Authors:  Ryszard M Pluta; John A Butman; Bawarjan Schatlo; Dennis L Johnson; Edward H Oldfield
Journal:  J Neurosurg       Date:  2009-11       Impact factor: 5.115

4.  Delayed Cerebral Ischemia After Subarachnoid Hemorrhage: Experimental-Clinical Disconnect and the Unmet Need.

Authors:  Fumiaki Oka; David Y Chung; Michiyasu Suzuki; Cenk Ayata
Journal:  Neurocrit Care       Date:  2020-02       Impact factor: 3.210

5.  Heparin and related drugs: beyond anticoagulant activity.

Authors:  Clive Page
Journal:  ISRN Pharmacol       Date:  2013-07-30
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.